163 results
POS AM
ABVC
ABVC BioPharma Inc
25 Apr 24
Prospectus update (post-effective amendment)
2:38pm
).
Strategy
Key elements of our business strategy include:
Advancing to the pivotal trial phase of ABV-1701 Vitargus® for the treatments of Retinal … to successfully execute our long-term growth strategy during these uncertain times;
our ability to recruit the necessary number of patients to complete future
424B4
ABVC
ABVC BioPharma Inc
5 Apr 24
Prospectus supplement with pricing info
2:47pm
are in compliance with Nasdaq Listing Rule 5550(b)(1).
Strategy
Key elements of our business strategy include:
Advancing to the pivotal trial phase of ABV … long-term growth strategy during these uncertain times;
our ability to recruit the necessary number of patients to complete future clinical trials
DEFA14A
ABVC
ABVC BioPharma Inc
25 Mar 24
Additional proxy soliciting materials
4:30pm
strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. Such forward-looking statements involve known … the Company with a seat on Rgene’s Board of Directors until the loan is repaid in full. The Company has nominated Dr. Jiang, its Chief Strategy
8-K/A
EX-99.1
k0sihfgm1 s9vo3
26 Jan 24
Report of Independent Registered Public Accounting Firm
12:00am
8-K
EX-10.1
orxr16kixvz0ce 6fc84
17 Jan 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
zt7wfaoqef3dlmx8tj4t
20 Nov 23
Entry into a Material Definitive Agreement
8:30am
424B4
jj5u9to5wcbnj
17 Nov 23
Prospectus supplement with pricing info
5:00pm
424B4
1iytkuscs 36f
17 Nov 23
Prospectus supplement with pricing info
5:00pm
424B3
x60hyuntv2uohd
17 Nov 23
Prospectus supplement
5:00pm
424B4
tdi8aiyu
17 Aug 23
Prospectus supplement with pricing info
5:00pm
424B3
1t0mn5jqpfluf
17 Aug 23
Prospectus supplement
5:00pm